Apple Is Lobbying Biden Administration to Overturn Apple Watch Patent Ban
Karl Evers-Hillstrom, reporting for The Hill:
The U.S. International Trade Commission (ITC) ruled in December
that Apple infringed on medical device company AliveCor’s wearable
electrocardiogram patents. The commission’s ruling could result in
an import ban on popular Apple Watch models, unless the Biden
administration steps in.
Apple responded by contracting with Shara Aranoff, a lobbyist at
Covington & Burling who chaired the ITC during the Obama
administration.
I’m not sure what to make of the patent claims here. But this doesn’t sound right to me:
AliveCor told The Hill that it believed that it had a good
relationship with the Silicon Valley giant and went on to sell an
ECG accessory for the Apple Watch. But in 2018, Apple launched an
Apple Watch with a built-in ECG sensor and made third-party heart
monitoring software incompatible with the product, forcing
AliveCor to cancel sales of its product.
“We come up with new technologies, and instead of the ecosystem
letting us thrive and continue to build on top of the innovations
we already have, Apple cuts us out up front, steals our
technology, uses their platform power to scale it, and now is
basically saying it’s scaled so it can’t be cut off,” Abani said.
Here’s a MacRumors story from 2017 about AliveCor’s $200 Kardia Band accessory, which is seemingly at the heart of this dispute. It sounds to me not that Apple “stole” any specific technology from AliveCor but rather that AliveCor is asserting that its patents give them exclusive rights to the idea of an ECG sensor that connects to a smart watch.
I’m also not sure how to square this controversy with the fact that Apple seemingly won a decision regarding these patents from the U.S. Patent and Trademark Office in December. But the stakes are serious for Apple: all of the Series 8 and Ultra models have ECG sensors; the only model Apple still sells without one is the SE. Surely the upcoming Series 9 (and Ultra 2?) models have ECG sensors as well.
The other thing that struck me, as ever, with The Hill’s report is how low the financial stakes are for political lobbying:
Long a darling on Capitol Hill, Apple has aggressively bolstered
its lobbying presence in recent years as lawmakers began to
closely scrutinize its market dominance. Apple spent nearly $9.4
million on lobbying in 2022, the highest figure in the company’s
history, according to nonpartisan research group OpenSecrets.
$9.4 million is loose pocket change for Apple. The company generated about $95 billion in profit over its last four financial quarters. So (does some back-of-the-envelope math) Apple spends about one hour of its annual profit on lobbying.
★
Karl Evers-Hillstrom, reporting for The Hill:
The U.S. International Trade Commission (ITC) ruled in December
that Apple infringed on medical device company AliveCor’s wearable
electrocardiogram patents. The commission’s ruling could result in
an import ban on popular Apple Watch models, unless the Biden
administration steps in.
Apple responded by contracting with Shara Aranoff, a lobbyist at
Covington & Burling who chaired the ITC during the Obama
administration.
I’m not sure what to make of the patent claims here. But this doesn’t sound right to me:
AliveCor told The Hill that it believed that it had a good
relationship with the Silicon Valley giant and went on to sell an
ECG accessory for the Apple Watch. But in 2018, Apple launched an
Apple Watch with a built-in ECG sensor and made third-party heart
monitoring software incompatible with the product, forcing
AliveCor to cancel sales of its product.
“We come up with new technologies, and instead of the ecosystem
letting us thrive and continue to build on top of the innovations
we already have, Apple cuts us out up front, steals our
technology, uses their platform power to scale it, and now is
basically saying it’s scaled so it can’t be cut off,” Abani said.
Here’s a MacRumors story from 2017 about AliveCor’s $200 Kardia Band accessory, which is seemingly at the heart of this dispute. It sounds to me not that Apple “stole” any specific technology from AliveCor but rather that AliveCor is asserting that its patents give them exclusive rights to the idea of an ECG sensor that connects to a smart watch.
I’m also not sure how to square this controversy with the fact that Apple seemingly won a decision regarding these patents from the U.S. Patent and Trademark Office in December. But the stakes are serious for Apple: all of the Series 8 and Ultra models have ECG sensors; the only model Apple still sells without one is the SE. Surely the upcoming Series 9 (and Ultra 2?) models have ECG sensors as well.
The other thing that struck me, as ever, with The Hill’s report is how low the financial stakes are for political lobbying:
Long a darling on Capitol Hill, Apple has aggressively bolstered
its lobbying presence in recent years as lawmakers began to
closely scrutinize its market dominance. Apple spent nearly $9.4
million on lobbying in 2022, the highest figure in the company’s
history, according to nonpartisan research group OpenSecrets.
$9.4 million is loose pocket change for Apple. The company generated about $95 billion in profit over its last four financial quarters. So (does some back-of-the-envelope math) Apple spends about one hour of its annual profit on lobbying.